Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Endothelin antagonism in pulmonary hypertension, heart failure, and beyond.

Literature DB >> 15894792

Endothelin antagonism in pulmonary hypertension, heart failure, and beyond.

T Attinà¹, R Camidge, D E Newby, D J Webb.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2005 PMID： 15894792 PMCID： PMC1768938 DOI： 10.1136/hrt.2004.053991

Source DB: PubMed Journal: Heart ISSN： 1355-6037 Impact factor: 5.994

× No keyword cloud information.

20 in total

Review 1. Endothelin antagonists.

Authors: A Benigni; G Remuzzi
Journal: Lancet Date: 1999-01-09 Impact factor: 79.321

2. Salt-sensitive hypertension in endothelin-B receptor-deficient rats.

Authors: C E Gariepy; T Ohuchi; S C Williams; J A Richardson; M Yanagisawa
Journal: J Clin Invest Date: 2000-04 Impact factor: 14.808

3. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure.

Authors: R Pacher; B Stanek; M Hülsmann; J Koller-Strametz; R Berger; M Schuller; E Hartter; E Ogris; B Frey; G Heinz; G Maurer
Journal: J Am Coll Cardiol Date: 1996-03-01 Impact factor: 24.094

4. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.

Authors: A Giaid; M Yanagisawa; D Langleben; R P Michel; R Levy; H Shennib; S Kimura; T Masaki; W P Duguid; D J Stewart
Journal: N Engl J Med Date: 1993-06-17 Impact factor: 91.245

5. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure.

Authors: S Sakai; T Miyauchi; M Kobayashi; I Yamaguchi; K Goto; Y Sugishita
Journal: Nature Date: 1996-11-28 Impact factor: 49.962

Review 6. Endothelin as a regulator of cardiovascular function in health and disease.

Authors: W G Haynes; D J Webb
Journal: J Hypertens Date: 1998-08 Impact factor: 4.844

7. Aortic arch malformations and ventricular septal defect in mice deficient in endothelin-1.

Authors: Y Kurihara; H Kurihara; H Oda; K Maemura; R Nagai; T Ishikawa; Y Yazaki
Journal: J Clin Invest Date: 1995-07 Impact factor: 14.808

8. Contribution of endogenous generation of endothelin-1 to basal vascular tone.

Authors: W G Haynes; D J Webb
Journal: Lancet Date: 1994-09-24 Impact factor: 79.321

9. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure.

Authors: W Kiowski; G Sütsch; P Hunziker; P Müller; J Kim; E Oechslin; R Schmitt; R Jones; O Bertel
Journal: Lancet Date: 1995-09-16 Impact factor: 79.321

10. Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade.

Authors: Jane Goddard; Neil R Johnston; Malcolm F Hand; Allan D Cumming; Ton J Rabelink; Andrew J Rankin; David J Webb
Journal: Circulation Date: 2004-02-23 Impact factor: 29.690

28 in total

1. Clinical trials of endothelin antagonists in heart failure: publication is good for the public health.

Authors: N F Kelland; D J Webb
Journal: Heart Date: 2007-01 Impact factor: 5.994

2. Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products.

Authors: James W Dear; Pajaree Lilitkarntakul; David J Webb
Journal: Br J Clin Pharmacol Date: 2006-09 Impact factor: 4.335

3. Right-sided heart failure: diagnosis and treatment strategies.

Authors: Jennifer Cowger Matthews; Todd F Dardas; Michael P Dorsch; Keith D Aaronson
Journal: Curr Treat Options Cardiovasc Med Date: 2008-08

4. Regulation of vascular contractility and blood pressure by the E2F2 transcription factor.

Authors: Junlan Zhou; Yan Zhu; Min Cheng; Deepika Dinesh; Tina Thorne; Kian Keong Poh; Dongxu Liu; Chantal Botros; Yao Liang Tang; Nichole Reisdorph; Raj Kishore; Douglas W Losordo; Gangjian Qin
Journal: Circulation Date: 2009-09-14 Impact factor: 29.690